TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse models

Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity

Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects

Therapeutic vaccine-induced plasma cell differentiation is defective in the presence of persistently high HBsAg levels

Swine pseudorabies virus attenuated vaccine reprograms the kidney cancer tumor microenvironment and synergizes with PD-1 blockade

A Dual-domain Engineered Antibody for Efficient HBV Suppression and Immune Responses Restoration

Micronanoparticled risedronate exhibits potent vaccine adjuvant effects

A glycoengineered therapeutic anti-HBV antibody that allows increased HBsAg immunoclearance improves HBV suppression <i>in vivo</i>

Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

MHC class II regulation of CD8+T cell tolerance and implications in autoimmunity and cancer immunotherapy

The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors

Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD

Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters

Combination therapy of therapeutic antibody and vaccine or entecavir in HBV carrier mice

A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19

Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine

New discovery of high-affinity SARS-CoV-2 spike S2 protein binding peptide selected by PhIP-Seq

Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines

The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2

Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials

Pre-Clinical Development of a Potent Neutralizing Antibody MW3321 With Extensive SARS-CoV-2 Variants Coverage

Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron

A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice

Cross-species tropism and antigenic landscapes of SARS-CoV-2 variants

A broad-spectrum nanobody targeting the C-terminus of the hepatitis B surface antigen for chronic hepatitis B infection therapy

A review of the safety and efficacy of current COVID-19 vaccines

Azacytidine targeting SARS-CoV-2 viral RNA as a potential treatment for COVID-19

A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway (vol 8, pg 549, 2018)

A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

Efficient intracellular delivery of proteins by a multifunctional chimaeric peptide in vitro and in vivo

A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters

Gender associates with both susceptibility to infection and pathogenesis of SARS-CoV-2 in Syrian hamster

Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro

Virus-Free and Live-Cell Visualizing SARS-CoV-2 Cell Entry for Studies of Neutralizing Antibodies and Compound Inhibitors

Preparation and functional evaluation of monoclonal antibodies targeting Hepatitis B Virus Polymerase

Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection

Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice

Structure guided maturation of a novel humanized anti-HBV antibody and its preclinical development

SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates

Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells

Nanobody-based sandwich reporter system for living cell sensing influenza A virus infection

HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation

Role of quantitative hepatitis B core antibody levels in predicting significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase levels

The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice

A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway

The gRNA-miRNA-gRNA Ternary Cassette Combining CRISPR/Cas9 with RNAi Approach Strongly Inhibits Hepatitis B Virus Replication